Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia

Clinical trial NCT00354809 · COMPLETED

Trial details

NCT number: NCT00354809
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sleep Initiation and Maintenance Disorders Insomnia

Start date: 2006-05-01
Primary completion: 2007-07-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.